Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today that the ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Toxic mold poses a serious health threat, and in rare cases, exposure to high levels of harmful mold spores can even be fatal. Recognizing the potential for mold toxicity and its various symptoms is ...

Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville 20850, Maryland, United States ...

Chulabhorn International College of Medicine, Thammasat University, Pathumthani 10120, Thailand Department of Basic Medical Sciences, Faculty of Medicine, Siam University, Bangkok 10160, Thailand ...

In laboratory animal studies, the technical grade active ingredient, Pelargonic Acid Technical, was of low toxicity via oral and dermal routes, and slightly acutely toxic by the inhalation route. It ...

The substance is expected to have high subchronic toxicity by the oral route (90-day no-observed-effect level (NOEL) <100 mg/kg-bw/day) and high subchronic toxicity by the dermal route (28-day NOAEL ...

We conclude that in mouse and human skin acute UVB exposure results in a transient loss of papillary fibroblasts, which is associated with dermal thickening, recruitment of immune cells, and an ...

We review the current data about CHG use in this susceptible population, focusing on neonates <32 weeks gestation and highlighting the two biggest areas of concern, skin toxicity and systemic ...